Literature DB >> 21320596

Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU).

Alexandr Nemec1, Lenka Krizova, Martina Maixnerova, Tanny J K van der Reijden, Pieter Deschaght, Virginie Passet, Mario Vaneechoutte, Sylvain Brisse, Lenie Dijkshoorn.   

Abstract

Acinetobacter genomic species (gen. sp.) 3 and gen. sp. 13TU are increasingly recognized as clinically important taxa within the Acinetobacter calcoaceticus-Acinetobacter baumannii (ACB) complex. To define the taxonomic position of these genomic species, we investigated 80 strains representing the known diversity of the ACB complex. All strains were characterized by AFLP analysis, amplified rDNA restriction analysis and nutritional or physiological testing, while selected strains were studied by 16S rRNA and rpoB gene sequence analysis, multilocus sequence analysis and whole-genome comparison. Results supported the genomic distinctness and monophyly of the individual species of the ACB complex. Despite the high phenotypic similarity among these species, some degree of differentiation between them could be made on the basis of growth at different temperatures and of assimilation of malonate, l-tartrate levulinate or citraconate. Considering the medical relevance of gen. sp. 3 and gen. sp. 13TU, we propose the formal names Acinetobacter pittii sp. nov. and Acinetobacter nosocomialis sp. nov. for these taxa, respectively. The type strain of A. pittii sp. nov. is LMG 1035(T) (=CIP 70.29(T)) and that of A. nosocomialis sp. nov. is LMG 10619(T) (=CCM 7791(T)).
Copyright © 2011 Institut Pasteur. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320596     DOI: 10.1016/j.resmic.2011.02.006

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  110 in total

1.  A taxonomically unique Acinetobacter strain with proteolytic and hemolytic activities recovered from a patient with a soft tissue injury.

Authors:  Marisa Almuzara; German Matías Traglia; Lenka Krizova; Claudia Barberis; Sabrina Montaña; Romina Bakai; Alicia Tuduri; Carlos Vay; Alexandr Nemec; María Soledad Ramírez
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  Human leptospira isolates circulating in Mayotte (Indian Ocean) have unique serological and molecular features.

Authors:  P Bourhy; L Collet; T Lernout; F Zinini; R A Hartskeerl; Hans van der Linden; J M Thiberge; L Diancourt; S Brisse; C Giry; F Pettinelli; M Picardeau
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

3.  Draft genome sequence of an Acinetobacter genomic species 3 strain harboring a bla(NDM-1) gene.

Authors:  Yong Chen; Yujun Cui; Fei Pu; Guoqin Jiang; Xiangna Zhao; Yanting Yuan; Wei Zhao; Dongfang Li; Hui Liu; Yin Li; Ting Liang; Li Xu; Yan Wang; Qing Song; Jiyong Yang; Long Liang; Ruifu Yang; Li Han; Yajun Song
Journal:  J Bacteriol       Date:  2012-01       Impact factor: 3.490

4.  First identification of OXA-72 carbapenemase from Acinetobacter pittii in Colombia.

Authors:  Maria Camila Montealegre; Juan José Maya; Adriana Correa; Paula Espinal; Maria F Mojica; Sory J Ruiz; Fernando Rosso; Jordi Vila; John P Quinn; Maria Virginia Villegas
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

5.  Old Clinical Isolates of Acinetobacter seifertii in Brazil Producing OXA-58.

Authors:  Rodrigo Cayô; Fernanda Rodrigues-Costa; Adriana Pereira Matos; Cecilia Godoy Carvalhaes; Lenie Dijkshoorn; Ana Cristina Gales
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

6.  KatG and KatE confer Acinetobacter resistance to hydrogen peroxide but sensitize bacteria to killing by phagocytic respiratory burst.

Authors:  Daqing Sun; Sara A Crowell; Christian M Harding; P Malaka De Silva; Alistair Harrison; Dinesh M Fernando; Kevin M Mason; Estevan Santana; Peter C Loewen; Ayush Kumar; Yusen Liu
Journal:  Life Sci       Date:  2016-02-06       Impact factor: 5.037

7.  Molecular Epidemiology and Mechanism of Sulbactam Resistance in Acinetobacter baumannii Isolates with Diverse Genetic Backgrounds in China.

Authors:  Yunxing Yang; Ying Fu; Peng Lan; Qingye Xu; Yan Jiang; Yan Chen; Zhi Ruan; Shujuan Ji; Xiaoting Hua; Yunsong Yu
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

8.  A Prospective Study of Acinetobacter baumannii Complex Isolates and Colistin Susceptibility Monitoring by Mass Spectrometry of Microbial Membrane Glycolipids.

Authors:  Lisa M Leung; Christi L McElheny; Francesca M Gardner; Courtney E Chandler; Sarah L Bowler; Roberta T Mettus; Caressa N Spychala; Erin L Fowler; Belita N A Opene; Robert A Myers; David R Goodlett; Yohei Doi; Robert K Ernst
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

9.  Identification, genotypic relation, and clinical features of colistin-resistant isolates of Acinetobacter genomic species 13BJ/14TU from bloodstreams of patients in a university hospital.

Authors:  Seung Yeob Lee; Jong Hee Shin; Kyung Hwa Park; Ju Hee Kim; Myung Geun Shin; Soon Pal Suh; Dong Wook Ryang; Soo Hyun Kim
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

10.  High frequency of Acinetobacter soli among Acinetobacter isolates causing bacteremia at a tertiary hospital in Japan.

Authors:  Shiro Endo; Hisakazu Yano; Hajime Kanamori; Shinya Inomata; Tetsuji Aoyagi; Masumitsu Hatta; Yoshiaki Gu; Koichi Tokuda; Miho Kitagawa; Mitsuo Kaku
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.